Treatment of type II gastric carcinoid tumors with somatostatin analogues

N Engl J Med. 2000 Aug 24;343(8):551-4. doi: 10.1056/NEJM200008243430805.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Carcinoid Tumor / drug therapy*
  • Carcinoid Tumor / etiology
  • Female
  • Gastrins / blood
  • Humans
  • Male
  • Middle Aged
  • Multiple Endocrine Neoplasia Type 1 / complications
  • Octreotide / therapeutic use*
  • Peptides, Cyclic / therapeutic use*
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use*
  • Stomach Neoplasms / drug therapy*
  • Stomach Neoplasms / etiology
  • Zollinger-Ellison Syndrome / complications

Substances

  • Antineoplastic Agents
  • Gastrins
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
  • Octreotide